MIRA INFORM REPORT

 

 

 

Report Date :

18.11.2008

 

IDENTIFICATION DETAILS

 

Name :

LIFELINE INDUSTRIES LIMITED

 

 

Registered Office :

A Wing, 401, Master Mind III, Royal Palm Aarey Milk Colony, Goregaon (East), Mumbai - 400065, Maharashtra

 

 

Country :

India

 

 

Financials (as on) :

31.03.2007

 

 

Date of Incorporation :

24.03.1986

 

 

Com. Reg. No.:

11-39313

 

 

CIN No.:

[Company Identification No.]

U24110MH1986PLC039313

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

MUMS34691G

 

 

PAN No.:

[Permanent Account No.]

AACCS3496E

 

 

Legal Form :

A Closely Held Public Limited Liability Company

 

 

Line of Business :

Manufacturer of Bulk Drugs and Chemicals.

 

RATING & COMMENTS

 

MIRA’s Rating :

B

 

RATING

STATUS

PROPOSED CREDIT LINE

26-40

B

Unfavourable & favourable factors carry similar weight in credit consideration. Capability to overcome financial difficulties seems comparatively below average.

Small

 

Maximum Credit Limit :

USD 200000

 

 

Status :

Moderate

 

 

Payment Behaviour :

Slow but Correct

 

 

Litigation :

Clear

 

 

Comments :

Subject is an established company having moderate track. Payments are reported as slow but correct. Profit margin is under severe pressure.

 

The company can be considered for small to mediocre business dealings at usual trade terms and conditions.

 

 

INFORMATION PARTED BY

 

Name :

Mr. Ravi Vishvakarma

Designation :

Finance Officer

Date :

15.11.2008

 

 

LOCATIONS

 

Registered Office :

A Wing, 401, Master Mind III, Royal Palm Aarey Milk Colony, Goregaon (East), Mumbai - 400065, Maharashtra, India

Tel. No.:

91-22-28794115

Mobile No.:

91-9322282875

E-Mail :

nikunjkanakia@lifelinepharma.in

info@lifelinepharma.in

Website :

http://www.lifelinepharma.net

Area :

9000 sq. ft.

Location :

Owned

 

 

Corporate Office :

A – 25, Virwani Industrial Estate, Western Express Highway, Goregaon, Mumbai – 400063, Maharashtra, India

Tel. No.:

 

Fax No.:

91-22-28506465

 

 

Factory :

B -10, MIDC Akkalkot Road, Solapur, India

Tel. No.:

91-217-2652036

Area :

4000 sq. ft.

Location :

Leased

 

 

DIRECTORS

 

Name :

Mr. Kirtikumar M. Kanakia

Designation :

Director

Address :

Flat No.701/702, Quarter Deck Co-Op Housing Limited, 7 Bunglow J. P. Road, Andheri (West), Mumbai – 400058, Maharashtra, India

Date of Birth/Age :

11.11.1948

Date of Appointment :

02.05.2005

Email :

kirtibhai@prominent-travels.com

 

 

Name :

Mr. Prakash Raval

Designation :

Director

Address :

A – 16, 3rd Floor, Chitralaya, Behind Hotel Contessa, K P Nagar, Boisar, Thane – 401501, Maharashtra, India

Date of Birth/Age :

01.11.1964

Date of Appointment :

18.11.2004

 

 

Name :

Mr. Nikunj Kanakia

Designation :

Director

Address :

Flat No.701/702, Quarter Deck Co-Op Housing Limited, 7 Bunglow J. P. Road, Andheri (West), Mumbai – 400058, Maharashtra, India

Date of Birth/Age :

22.06.1975

Date of Appointment :

02.05.2005

 

 

KEY EXECUTIVES

 

Name :

Mr. Navneet V. Bhalani

Designation :

Company Secretary

Address :

602 Shwetambari, N. S. Road, No.5 (Estansion) Juhu Scheme, Mumbai – 400049, Maharashtra, India

Date of Birth/Age :

15.10.1969

Date of Appointment :

01.03.2008

Email :

Navneet.bhalani@rediffmail.com

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

(As on 10.09.2007)

Names of Shareholders

 

No. of Shares

 

 

 

Nikunj Kanakia

 

1380640

Kirtikumar M. Kanakia

 

1449090

Heena Kanakia

 

10

Jayshree Kanakia

 

10

Inland Impex Private Limited

 

275550

Riviera Mercantile Private Limited

 

342000

Anil Jain

 

11750

Aditya Jain

 

139500

Tarachand Jain

 

60000

Sunil Jain

 

48000

Rajani Rahurikar

 

18000

Ashok Chawala

 

6500

Sarla Chawla

 

5950

Kishore Chawla

 

6000

Santosh Kotecha

 

1500

Manish Kotecha

 

1000

Surendra Kotecha

 

1000

Rajkumar Jain

 

2000

Nirmaladevi Jain

 

1500

Gunvantrai Changela

 

4000

 

 

 

Total

 

3754000

 


 

(As on 14.08.2008)

Names of Allottees

 

No. of Shares

Allottes

 

 

 

Kirtikumar M. Kanakia

 

144600

Nikunj Kanakia

 

70840

Prakash Rawal

 

7

N. K. Exim Private Limited

 

61884

Lifeline Drugs Private Limited

 

85169

 

 

 

Total

 

362500

 

(As on 29.09.2007)

Category

 

Percentage

 

 

 

Bodies Corporate

 

16.45

Directors of relatives of directors

 

75.37

Other top fifty shareholders (Other than listed above)

 

8.18

 

 

 

Total

 

100.00

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturer of Bulk Drugs and Chemicals.

 

 

Exports :

 

Countries :

Middle East

 

 

Imports :

 

Countries :

China

 

 

Terms :

 

Selling :

Depends

 

 

Purchasing :

Depends

 

 

GENERAL INFORMATION

 

Customers :

  • End Users
  • Trader

 

 

No. of Employees :

100 (Office – 30 and Factory – 70) (Contract Workers – 40)

 

 

Bankers :

  • Canara Bank

Khar (West) Branch, P D Hinduja Marg, Khar West, Mumbai – 400052, Maharashtra, India

 

 

Facilities :

Secured Loans

31.03.2007

(Rs. In Millions)

 

 

Canara Bank Term Loan I

28.273

Canara Bank Term Loan II

12.900

Canara Bank Working Capital Loan

126.097

Canara Bank DPN Loan

5.000

Motor Car Loans from Banks and Institutions

2.061

 

 

Total

174.331

 

Unsecured Loans

31.03.2007

(Rs. In Millions)

 

 

From Members, Directors and Other relatives

113.308

Sales Tax Deferred Loan Payable

15.103

 

 

Total

128.411

 

 

 

Banking Relations :

Satisfactory

 

 

Auditors :

 

Name :

Atul C. Shah and Associates

Chartered Accountant

Address :

A/ 101, Sharda Gram, Mathuradas Road, Kandivli (West), Mumbai – 400067, Maharashtra, India

 

 

CAPITAL STRUCTURE

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

3750000

Equity Shares

Rs.10/- each

Rs.37.500 Millions

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

3750000

Equity Shares

Rs.10/- each

Rs.37.500 Millions

 

 

 

 

 


 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2007

31.03.2006

31.03.2005

SHAREHOLDERS FUNDS

 

 

 

1] Share Capital

37.500

15.135

15.135

2] Share Application Money

0.000

20.050

6.050

3] Reserves & Surplus

8.462

3.158

3.158

4] (Accumulated Losses)

0.000

(19.171)

(22.687)

NETWORTH

45.962

19.172

1.656

LOAN FUNDS

 

 

 

1] Secured Loans

174.331

75.299

26.673

2] Unsecured Loans

128.411

79.697

16.132

TOTAL BORROWING

302.742

154.996

42.805

DEFERRED TAX LIABILITIES

10.928

7.212

0.000

 

 

 

 

TOTAL

359.632

200.550

44.461

 

 

 

 

APPLICATION OF FUNDS

 

 

 

 

 

 

 

FIXED ASSETS [Net Block]

114.361

41.813

41.861

Capital work-in-progress

0.000

17.348

0.000

 

 

 

 

INVESTMENT

0.420

0.420

0.420

DEFERREX TAX ASSETS

0.000

0.000

0.000

 

 

 

 

CURRENT ASSETS, LOANS & ADVANCES

 

 

 

 

Inventories

115.649

108.291

3.309

 

Sundry Debtors

115.506

26.933

0.599

 

Cash & Bank Balances

3.737

3.122

0.243

 

Other Current Assets

0.000

0.000

0.000

 

Loans & Advances

47.264

19.835

10.242

Total Current Assets

282.156

158.181

14.393

Less : CURRENT LIABILITIES & PROVISIONS

 

 

 

 

Current Liabilities

36.059

35.248

12.213

 

Provisions

1.246

1.134

0.000

Total Current Liabilities

37.305

36.382

12.213

Net Current Assets

244.851

121.799

2.180

 

 

 

 

MISCELLANEOUS EXPENSES

0.000

0.000

0.000

 

 

 

 

TOTAL

359.632

200.550

44.461

 


 

PROFIT & LOSS ACCOUNT

 

PARTICULARS

 

31.03.2007

31.03.2006

31.03.2005

Sales Turnover

773.302

248.474

11.036

Other Income

0.256

3.232

27.263

Total Income

773.558

251.706

38.299

 

 

 

 

Profit/(Loss) Before Tax

28.405

11.823

11.129

Provision for Taxation

3.929

8.307

0.000

Profit/(Loss) After Tax

24.476

3.516

11.129

 

 

 

 

Export Value

54.679

NA

NA

 

 

 

 

Expenditures :

 

 

 

 

Raw Material Consumed

693.860

265.982

8.511

 

Manufacturing Expenses

15.564

11.024

9.830

 

Administrative Expenses

11.629

5.430

3.306

 

Financial Charges

18.491

8.121

1.192

 

Depreciation & Amortization

5.609

4.105

2.526

 

Increase/(Decrease) in Finished Goods

0.000

(54.779)

1.805

Total Expenditure

745.153

239.883

27.170

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2007

31.03.2006

31.03.2005

PAT / Total Income

(%)

3.16

1.40

29.06

 

 

 

 

 

Net Profit Margin

(PBT/Sales)

(%)

3.67

4.76

100.84

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

7.16

5.91

19.78

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

0.62

0.62

6.72

 

 

 

 

 

Debt Equity Ratio

(Total Liability/Networth)

 

7.40

9.98

33.22

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

7.56

4.35

1.18

 


 

LOCAL AGENCY FURTHER INFORMATION

 

Note:

 

The Registered Office of the company has been shifted from No.8, New Tejpal Industrial Estate, Andheri Kurla Road, Sakinaka, Mumbai – 400072, Maharashtra, India, to the present address w.e.f. 01.06.2007.

 

They had 3 Sister Companies but they are going to merge into Lifeline Industries Limited

 

 

Trade Reference:

 

 

Fixed Assets:

 

 

 

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No records exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                  None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                          None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                          None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 

 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.49.46

UK Pound

1

Rs.73.17

Euro

1

Rs.62.96

 

 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

6

PAID-UP CAPITAL

1~10

5

OPERATING SCALE

1~10

4

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

4

--PROFITABILIRY

1~10

2

--LIQUIDITY

1~10

4

--LEVERAGE

1~10

4

--RESERVES

1~10

4

--CREDIT LINES

1~10

4

--MARGINS

-5~5

-

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

YES

--AFFILIATION

YES/NO

NO

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

TOTAL

 

37

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Unfavourable & favourable factors carry similar weight in credit consideration. Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

NR

In view of the lack of information, we have no basis upon which to recommend credit dealings

No Rating

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions